Colorado Spa Halted Use of Unapproved Cosmetic Injections
Three patients reported neurologic symptoms after receiving illicit botulinum toxin injections in Colorado.
Updated on Oct. 14, 2026 in Beauty
Live Poll
Should states impose stricter oversight on the products used by medical spas in your area?
Health officials in Colorado have ordered a medical spa to cease the use of unapproved botulinum toxin products following reports of adverse reactions. Three women experienced neurologic symptoms including muscle weakness and blurred vision after receiving cosmetic injections at the facility.
Why it matters
This enforcement action highlights the critical health risks associated with receiving cosmetic injections from providers using unverified or illicit products. Improper sourcing, concentration, or storage of these neurotoxins can lead to severe systemic symptoms that require immediate medical attention.
A state investigation confirmed that three women experienced neurologic symptoms following the use of unapproved botulinum neurotoxin products. The findings identified inappropriate product storage and administration at the facility, though the exact contaminant levels remain under investigation.
The players
Colorado Department of Public Health and Environment
The state agency responsible for overseeing medical facilities and protecting the public from unsafe healthcare practices.
Food and Drug Administration
The federal regulator tasked with ensuring the safety and efficacy of medical products, including cosmetic injectables.
Centers for Disease Control and Prevention
The national public health institute that monitors and investigates reports of serious illnesses, including toxin-related outbreaks.
The details
Botulinum toxin works by blocking nerve signals to muscles, causing temporary paralysis to smooth out fine lines and wrinkles. When products are unapproved, they may lack the necessary quality controls for potency or purity, leading to unintended systemic spread of the toxin. Patients in this instance reported symptoms such as numbness, tingling, dysphonia, and neck stiffness, likely resulting from improper preparation, contamination, or incorrect dosing of the unregulated substance.
Timeline
In 2024, the CDC investigated botulism cases linked to unapproved injections in Tennessee and New York.
During 2025, the FDA issued warnings to 18 websites found to be selling unapproved botulinum toxin products.
On October 14, 2026, health authorities in Colorado confirmed the medical spa had been ordered to stop using unapproved products.
Health Landscape
This enforcement action aligns with the broader regulatory effort established by the FDA's 2025 warning initiative against 18 websites selling unapproved BoNT products. It highlights the persistence of unregulated aesthetic procedures despite ongoing public health warnings regarding product sourcing.
If you are considering cosmetic injections, ensure your provider uses only FDA-approved products and can verify their supply chain. If you experience unexpected numbness, weakness, or blurred vision after a procedure, seek medical evaluation promptly and discuss these symptoms with your physician.
The takeaway
The primary safety risk in cosmetic procedures is the use of non-FDA approved substances that lack verified purity and concentration. Always ask your provider to demonstrate that the product they are using is FDA-approved and verify that the facility adheres to state safety and storage standards.
Further reading
For more on vetting aesthetic providers, explore our Beauty section.
Source note: This article includes information reported by Medscape.
Live Poll
Should states impose stricter oversight on the products used by medical spas in your area?
